Scarica l'app Stockscreener
2.96
6.86%
0.19
Dopo l'orario di chiusura:
2.90
-0.06
-2.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Altimmune Inc Borsa (ALT) Ultime notizie
Altimmune Inc (ALT) Balance Sheet - TradingKey
ALT|Altimmune Inc|Price:2.965|Chg%:+0.195 - TradingKey
Altimmune Market Sentiment - Benzinga España
ETFs Investing in Altimmune, Inc. Stocks - TradingView
Altimmune Inc (ALT) Income Statement - TradingKey
GOOGL Stock Price TodayAlphabet Inc Class A News, Charts, Retail Sentiment - Stocktwits
ALT Stock Has Nearly Halved In The Past Year, So Why Does Wall Street See Almost 500% Upside? - Stocktwits
Altimmune Inc (ALT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Altimmune Inc (ALT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Altimmune Inc (ALT) Institutional Confidence - TradingKey
Altimmune Inc (ALT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Altimmune Inc (ALT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Altimmune Inc (ALT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ALT|Altimmune Inc|Price:2.765|Chg%:-0.075 - TradingKey
Altimmune Inc (ALT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Altimmune (FRA:3G0) Selling and Marketing Expense : €0.00 Mil (TTM As of Mar. 2026) - GuruFocus
Altimmune, Inc. (ALT) Stock Analysis: Could a 444% Potential Upside Transform Your Portfolio? - DirectorsTalk Interviews
BABA: Alibaba Group Holding Ltd Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Altimmune Inc (ALT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ALT Stock Drops Pre-Market On Dilution Fears – Retail Calls It A ‘Horror Story’ - Stocktwits
Altimmune commits to advancing innovative therapies for MASH patients - Traders Union
Certain Common Stock of Altimmune, Inc. are subject to a Lock-Up Agreement Ending on 22-JUL-2026. - marketscreener.com
Certain Restricted Stock Units of Altimmune, Inc. are subject to a Lock-Up Agreement Ending on 22-JUL-2026. - marketscreener.com
VKTX Stock Outpaces LLY, ALT Ahead Of Earnings – Retail Eyes Breakout Ahead - Stocktwits
LULU, LCID, ALT Stocks Hit 52-Week Lows Today: What's Driving The Selloff? - Stocktwits
Altimmune advances research to address alcohol use disorder and liver disease link - Traders Union
Altimmune, Inc. Actuals & Estimates (DUS:3G0) - TradingView
Altimmune: Pemvidutide AUD Data Due Q3 Makes For Intriguing CatalystUpgrade (ALT) - Seeking Alpha
Here's why you should add Altimmune stock to your portfolio now - MSN
Leerink Sees Altimmune (ALT) As An Attractive Play In The MASH Therapeutics Market - Yahoo Finance
5 Overlooked Penny Stocks to Buy Right Now - Insider Monkey
Medicare Obesity Drug Coverage Puts These 3 Biotech Stocks In Focus - Sahm
Altimmune, Inc.(NasdaqGM:ALT) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Altimmune, Inc.(NasdaqGM: ALT) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Altimmune, Inc.(NasdaqGM: ALT) added to Russell 2000 Value Benchmark - marketscreener.com
Altimmune, Inc.(NasdaqGM: ALT) added to Russell Microcap Value Benchmark Index - marketscreener.com
Altimmune, Inc.(NasdaqGM: ALT) dropped from Russell 2000 Growth Benchmark - marketscreener.com
ALT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
Altimmune, Inc.(NasdaqGM: ALT) dropped from Russell 3000E Growth Benchmark - marketscreener.com
ALT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
ALT STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):